Sarah W Yip1, Kristi A Sacco, Tony P George, Marc N Potenza. 1. Division of Substance Abuse, Department of Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, 2 Church Street South, Suite 215, New Haven, CT, United States. sarah.yip@yale.edu
Abstract
BACKGROUND: Individuals with schizophrenia show deficits in cognitive functioning, as evidenced by deficits on neurocognitive tasks such as the Wisconsin Card Sorting Task (WCST). Studies of risk/reward decision-making in individuals with schizophrenia have yielded mixed results, and few studies have examined systematically the relationship between these domains and their relationship with clinical factors. METHOD: Thirty-two smokers with schizophrenia, ten non-smokers with schizophrenia, nine non-psychiatric non-smokers and ten non-psychiatric smokers were administered computerized versions of the Iowa Gambling Task (IGT) and the WCST. Smokers were allowed to smoke adlibitum during designated breaks in order to prevent deprivation. RESULTS: Subjects with schizophrenia performed significantly worse than non-psychiatric controls on both the IGT and the WCST, and performance on these tasks was significantly correlated across subject groups. Among women with schizophrenia, smokers performed significantly better than non-smokers on the IGT. CONCLUSIONS: Individuals with schizophrenia perform worse than controls on the IGT, suggesting impairments in risk/reward decision-making. Correlations between IGT and WCST performance suggest a shared element underlying task performance, such as a deficit in set-shifting or perseverance. Further research is needed to establish the relationship between cigarette smoking and IGT performance in schizophrenia.
BACKGROUND: Individuals with schizophrenia show deficits in cognitive functioning, as evidenced by deficits on neurocognitive tasks such as the Wisconsin Card Sorting Task (WCST). Studies of risk/reward decision-making in individuals with schizophrenia have yielded mixed results, and few studies have examined systematically the relationship between these domains and their relationship with clinical factors. METHOD: Thirty-two smokers with schizophrenia, ten non-smokers with schizophrenia, nine non-psychiatric non-smokers and ten non-psychiatric smokers were administered computerized versions of the Iowa Gambling Task (IGT) and the WCST. Smokers were allowed to smoke adlibitum during designated breaks in order to prevent deprivation. RESULTS: Subjects with schizophrenia performed significantly worse than non-psychiatric controls on both the IGT and the WCST, and performance on these tasks was significantly correlated across subject groups. Among women with schizophrenia, smokers performed significantly better than non-smokers on the IGT. CONCLUSIONS: Individuals with schizophrenia perform worse than controls on the IGT, suggesting impairments in risk/reward decision-making. Correlations between IGT and WCST performance suggest a shared element underlying task performance, such as a deficit in set-shifting or perseverance. Further research is needed to establish the relationship between cigarette smoking and IGT performance in schizophrenia.
Authors: Hana M Kester; Serge Sevy; Eldad Yechiam; Katherine E Burdick; Kelly L Cervellione; Sanjiv Kumra Journal: Schizophr Res Date: 2006-06-02 Impact factor: 4.939
Authors: José Manuel Rodríguez-Sánchez; Benedicto Crespo-Facorro; Rocío Perez-Iglesias; Rocío Perez Iglesias; César González-Blanch; César González-Blanch Bosch; Mario Alvarez-Jimenez; Mario Alvarez; Javier Llorca; José Luis Vázquez-Barquero Journal: Schizophr Res Date: 2005-09-15 Impact factor: 4.939
Authors: K F Berman; J L Ostrem; C Randolph; J Gold; T E Goldberg; R Coppola; R E Carson; P Herscovitch; D R Weinberger Journal: Neuropsychologia Date: 1995-08 Impact factor: 3.139
Authors: Kristi A Sacco; Angelo Termine; Aisha Seyal; Melissa M Dudas; Jennifer C Vessicchio; Suchitra Krishnan-Sarin; Peter I Jatlow; Bruce E Wexler; Tony P George Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Richard J Beninger; James Wasserman; Katherine Zanibbi; Danielle Charbonneau; Jennifer Mangels; Bruce V Beninger Journal: Schizophr Res Date: 2003-06-01 Impact factor: 4.939
Authors: Motoaki Nakamura; Paul G Nestor; James J Levitt; Adam S Cohen; Toshiro Kawashima; Martha E Shenton; Robert W McCarley Journal: Brain Date: 2007-12-03 Impact factor: 13.501
Authors: F Scott Hall; Andre Der-Avakian; Thomas J Gould; Athina Markou; Mohammed Shoaib; Jared W Young Journal: Neurosci Biobehav Rev Date: 2015-06-06 Impact factor: 8.989
Authors: Lisa Buchy; Larry J Seidman; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; William Stone; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel H Mathalon; Jean Addington Journal: Psychiatry Res Date: 2015-11-25 Impact factor: 3.222
Authors: Taryn G Moss; Kristi A Sacco; Taryn M Allen; Andrea H Weinberger; Jennifer C Vessicchio; Tony P George Journal: Drug Alcohol Depend Date: 2009-05-17 Impact factor: 4.492
Authors: Tracie A Paine; Samuel K Asinof; Geoffrey W Diehl; Anna Frackman; Joseph Leffler Journal: Behav Brain Res Date: 2013-01-24 Impact factor: 3.332